MX2021006488A - Composiciones para mejorar la funcion sexual. - Google Patents

Composiciones para mejorar la funcion sexual.

Info

Publication number
MX2021006488A
MX2021006488A MX2021006488A MX2021006488A MX2021006488A MX 2021006488 A MX2021006488 A MX 2021006488A MX 2021006488 A MX2021006488 A MX 2021006488A MX 2021006488 A MX2021006488 A MX 2021006488A MX 2021006488 A MX2021006488 A MX 2021006488A
Authority
MX
Mexico
Prior art keywords
compositions
sexual function
improving sexual
relates
present
Prior art date
Application number
MX2021006488A
Other languages
English (en)
Inventor
Djamaluddin Zaferan
Jahangir Khan
Original Assignee
Inxo As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inxo As filed Critical Inxo As
Publication of MX2021006488A publication Critical patent/MX2021006488A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a composiciones que comprenden L-arginina y L-citrulina en proporciones específicas. En particular, la presente invención se refiere al uso de tales composiciones para mejorar la función sexual en un sujeto humano sano.
MX2021006488A 2018-12-07 2019-12-06 Composiciones para mejorar la funcion sexual. MX2021006488A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201870801A DK180173B1 (en) 2018-12-07 2018-12-07 Compositions for improving sexual function
PCT/EP2019/083983 WO2020115274A1 (en) 2018-12-07 2019-12-06 Compositions for improving sexual function

Publications (1)

Publication Number Publication Date
MX2021006488A true MX2021006488A (es) 2021-09-23

Family

ID=70970572

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021006488A MX2021006488A (es) 2018-12-07 2019-12-06 Composiciones para mejorar la funcion sexual.

Country Status (12)

Country Link
US (2) US11304920B2 (es)
EP (1) EP3890718A1 (es)
JP (1) JP7459099B2 (es)
KR (1) KR20210100614A (es)
CN (2) CN113645965A (es)
AU (1) AU2019394090A1 (es)
BR (1) BR112021010203A2 (es)
CA (1) CA3121712A1 (es)
DK (1) DK180173B1 (es)
EA (1) EA202191446A1 (es)
MX (1) MX2021006488A (es)
WO (1) WO2020115274A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021030698A1 (en) * 2019-08-14 2021-02-18 Innovus Pharmaceuticals, Inc. Sensitization cream comprising l-arginine and l-citrulline and therapeutic uses thereof
CN113425383B (zh) * 2021-07-13 2023-02-10 新疆维吾尔自治区人民医院 一种泌尿外科用包皮吻合环切器
WO2024100574A1 (en) * 2022-11-08 2024-05-16 Swati Vishal Jajodia A herbal composition for management of sexual dysfunction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040062680A1 (en) 2002-09-30 2004-04-01 Bernard Technologies, Inc. Apparatus and method for generation of chlorine dioxide gas
WO2006002096A2 (en) * 2004-06-18 2006-01-05 Vivo Therapeutics, Inc. Low doses of l-citrulline for treating diseases
EP1754478B1 (en) 2005-08-04 2008-12-31 Extarma AG Liquid Composition comprising arginine and alpha-lipoic acid and its use for improvement of sexual function
CN101780181A (zh) * 2009-01-16 2010-07-21 陈祥槐 一氧化氮自由基保健品
US9265750B1 (en) 2010-02-22 2016-02-23 Gene C. Benckini Apparatus and method for correction of erectile dysfunction
SG186369A1 (en) 2010-06-25 2013-01-30 Horphag Res Ip Pre Ltd Composition for improving sexual wellness
CN103263018A (zh) 2013-04-27 2013-08-28 北京中国科学院老专家技术中心 一氧化氮功能饮料及其制备方法
US9572848B1 (en) 2014-03-26 2017-02-21 Aemes Research L.L.L.P. Composition of matter for sexual dysfunction
CN104382892A (zh) 2014-10-22 2015-03-04 何瑞红 增强体内一氧化氮数量和活性的组合物及其应用
US11241406B2 (en) 2015-08-28 2022-02-08 Nature's Sunshine Products, Inc. Compositions and methods for acutley raising nitric oxide levels

Also Published As

Publication number Publication date
BR112021010203A2 (pt) 2021-08-17
US20210353576A1 (en) 2021-11-18
CN113645965A (zh) 2021-11-12
EP3890718A1 (en) 2021-10-13
CA3121712A1 (en) 2020-06-11
US11304920B2 (en) 2022-04-19
DK201870801A8 (en) 2020-07-14
DK201870801A1 (en) 2020-07-07
AU2019394090A1 (en) 2021-06-24
US10993924B2 (en) 2021-05-04
US20200179321A1 (en) 2020-06-11
WO2020115274A1 (en) 2020-06-11
EA202191446A1 (ru) 2021-08-30
DK180173B1 (en) 2020-07-14
KR20210100614A (ko) 2021-08-17
JP7459099B2 (ja) 2024-04-01
CN115919828A (zh) 2023-04-07
JP2022514819A (ja) 2022-02-16

Similar Documents

Publication Publication Date Title
PH12019502279A1 (en) Cleaning compositions and uses thereof
MX2020001513A (es) Agentes de union a clec9a y su uso.
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
MX2019015311A (es) Composiciones de ésteres de ácido cannabidiólico y usos de las mismas.
MX2017001279A (es) Usos y composiciones de la flagelina.
MX2021001186A (es) Purinonas como inhibidores de proteasa especifica de ubiquitina 1.
SG10201907164SA (en) Rna containing composition for treatment of tumor diseases
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
MX2021006488A (es) Composiciones para mejorar la funcion sexual.
MX2020007008A (es) COMPOSICIONES Y MÉTODOS DE USO DE ß- HIDROXI-ß-METILBUTIRATO (HMB) ASOCIADO CON AYUNO INTERMITENTE.
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2020001885A (es) Formulaciones de daptomicina.
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
MX2017001396A (es) Metodos para mejorar el rendimiento miocardico en pacientes con cirugia de fontan que utilizan composiciones de udenafilo.
MY191337A (en) Compositions for the treatment of hypertension and/or fibrosis
MX2019009759A (es) Composiciones de peptido estables.
MX2019011613A (es) Formulaciones de acido 1-amino-1-ciclopropanocarboxilico.
MX2021006977A (es) Anellosomas y metodos de uso.
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
MX2017013879A (es) Composiciones que comprenden anakinra.
EA202092045A1 (ru) Лечение и предупреждение преэклампсии
MX2020002585A (es) Inhibidor de hdac combinado con un modulador del punto de control inmunitario para la terapia contra el cancer.